PROIETTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 673
EU - Europa 513
AS - Asia 178
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.366
Nazione #
US - Stati Uniti d'America 670
IE - Irlanda 130
IT - Italia 107
SE - Svezia 70
SG - Singapore 67
UA - Ucraina 64
HK - Hong Kong 42
FI - Finlandia 33
KR - Corea 33
CN - Cina 27
DE - Germania 26
RU - Federazione Russa 25
NL - Olanda 20
GB - Regno Unito 15
FR - Francia 9
IN - India 4
CH - Svizzera 3
LB - Libano 3
AT - Austria 2
CA - Canada 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IR - Iran 2
RO - Romania 2
AU - Australia 1
BE - Belgio 1
ES - Italia 1
EU - Europa 1
PA - Panama 1
PL - Polonia 1
Totale 1.366
Città #
Chandler 153
Dublin 130
San Mateo 72
Singapore 48
Hong Kong 42
Altamura 38
Boardman 37
Santa Clara 33
Medford 28
Princeton 28
Seoul 28
Wilmington 26
Lawrence 25
Perugia 24
Ann Arbor 23
Beijing 19
Des Moines 18
Andover 15
Saint Petersburg 12
Falls Church 11
Ashburn 10
Mondolfo 10
Helsinki 6
Rome 6
Jacksonville 4
Redwood City 4
Florence 3
Frankfurt am Main 3
Lausanne 3
Marino 3
San Paolo di Civitate 3
Woodbridge 3
Bucharest 2
Los Angeles 2
Mcallen 2
Moscow 2
Norwalk 2
Ponte 2
Brussels 1
Buffalo 1
Centro 1
Crespino 1
Fairport 1
Houston 1
Lonigo 1
Mumbai 1
Ottawa 1
Paris 1
Philadelphia 1
Portland 1
Prague 1
Praia A Mare 1
Prato 1
Qingdao 1
Stockholm 1
Sydney 1
Taiyuan 1
Toronto 1
Vienna 1
Totale 901
Nome #
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a prospective randomized study 103
IncobotulinumtoxinA in the treatment of neurogenic detrusor overactivity. 87
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up”. 82
Clinical and urodynamic efficacy of Xeomin in the treatment of neurogenic detrusor overactivity: preliminary results. 72
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 71
OnabotulinumtoxinA intravesical treatment in patients affected by overactive bladder syndrome: best practice in real-life management 68
Botulinum toxin Type-A activity in prostate cancer 61
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder 60
Botulinum toxin a enters normal human urothelial cells and modulates the sensory activity of bladder urothelium 58
Vesical urothelium and new concepts 56
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 52
Overactive bladder and sexual function: a nightmare couple 52
Normal human urothelial cell lines express onabotulinumtoxinA SV2 high affinity receptors. 46
Single-session Supine Bilateral Percutaneous Nephrolithotomy 45
OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results 45
ONABOTULINUM TOXIN A INTRADETRUSORIAL INJECTION MODALITY: SHALL WE TAKE A REST? 45
Contemporary management of the painful bladder: a systematic review. 41
TRATTAMENTO RIPETUTO CON MULTIPLE INFILTRAZIONI INTRADETRUSORIALI DI ONABOTULINUMTOSSINA A IN PAZIENTI AFFETTI DA VESCICA IPERATTIVA REFRATTARIA: RISULTATI A LUNGO TERMINE. 41
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease 40
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 38
Is retrograde intrarenal surgery for the treatment of renal stones with diameters exceeding 2 cm still a hazard? 38
Chronic prostatitis: How to give our best without apposite vagueness 37
Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence. 36
Six-year follow-up of intradetrusorial injections of botulinum toxin type a in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results 35
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis 31
Reply to Claus Riedl's Letter to the Editor re: Antonella Giannantoni, Vittorio Bini, Roger Dmochowski, et al. Contemporary Management of the Painful Bladder: A Systematic Review. 29
Resonance(A (R)) metallic stent in patients with ureterocutaneostomies 27
Overactive bladder 26
Totale 1.422
Categoria #
all - tutte 6.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 31 4 17 5 5 1
2020/2021146 2 11 8 12 58 15 4 1 17 8 7 3
2021/2022221 5 49 0 10 6 7 1 70 5 4 22 42
2022/2023481 31 99 9 45 32 53 0 15 166 2 18 11
2023/2024138 14 18 8 2 0 1 44 0 0 3 26 22
2024/2025157 33 31 28 7 44 14 0 0 0 0 0 0
Totale 1.422